Predicting physiological imbalance in Holstein dairy cows by three different sets of milk biomarkers.
Enzymes
FT-MIR
IgG N-glycans
Metabolic clusters
Metabolites
Random forests
Journal
Preventive veterinary medicine
ISSN: 1873-1716
Titre abrégé: Prev Vet Med
Pays: Netherlands
ID NLM: 8217463
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
20
10
2019
revised:
10
04
2020
accepted:
11
04
2020
pubmed:
4
5
2020
medline:
20
1
2021
entrez:
4
5
2020
Statut:
ppublish
Résumé
Blood biomarkers may be used to detect physiological imbalance and potential disease. However, blood sampling is difficult and expensive, and not applicable in commercial settings. Instead, individual milk samples are readily available at low cost, can be sampled easily and analysed instantly. The present observational study sampled blood and milk from 234 Holstein dairy cows from experimental herds in six European countries. The objective was to compare the use of three different sets of milk biomarkers for identification of cows in physiological imbalance and thus at risk of developing metabolic or infectious diseases. Random forests was used to predict body energy balance (EBAL), index for physiological imbalance (PI-index) and three clusters differentiating the metabolic status of cows created on basis of concentrations of plasma glucose, β-hydroxybutyrate (BHB), non-esterified fatty acids (NEFA) and serum IGF-1. These three metabolic clusters were interpreted as cows in balance, physiological imbalance and "intermediate cows" with physiological status in between. The three sets of milk biomarkers used for prediction were: milk Fourier transform mid-IR (FT-MIR) spectra, 19 immunoglobulin G (IgG) N-glycans and 8 milk metabolites and enzymes (MME). Blood biomarkers were sampled twice; around 14 days after calving (days in milk (DIM)) and around 35 DIM. MME and FT-MIR were sampled twice weekly 1-50 DIM whereas IgG N-glycan were measured only four times. Performances of EBAL and PI-index predictions were measured by coefficient of determination (R
Identifiants
pubmed: 32361640
pii: S0167-5877(19)30743-3
doi: 10.1016/j.prevetmed.2020.105006
pii:
doi:
Substances chimiques
Biomarkers
0
Fatty Acids, Nonesterified
0
Insulin-Like Growth Factor I
67763-96-6
3-Hydroxybutyric Acid
TZP1275679
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
105006Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest There is no direct financial interest of the authors and affiliations in the subject matter discussed in the manuscript. All financial support is identified in the Funding section.